At this time, only very limited funding is available that falls within CICCR's priority areas: male methods, vaginal methods that prevent pregnancy and sexually transmitted infections (STIs), and monthly methods for women.  Of highest interest would be activities that would make a project more attractive to an industrial partner.

 
“CONRAD engages in a Monitoring and Evaluation plan meant to measure CONRAD’s progress in the proposed research and development activities.  Successive and parallel stages of evaluation are undertaken, including CONRAD technical monitors’ assessments, periodic meetings of the Preclinical Working Group, Product Development Group, Clinical Team, Directors, and whole staff. Outside oversight will be provided by CONRAD’s Scientific Advisory Committee (SAC), a group of prominent investigators with expertise in HIV virology, STDs, preclinical testing and clinical research, pharmaceutical sciences, reproductive biology, obstetrics-gynecology, and microbicides.

 “For inquiries regarding funding opportunities through CICCR, please contact Mike Harper at 703.524.4744 or mharper@conrad.org and refer to “Guidelines for Applying to CICCR”